VPTDF 주가 차트
VPTDF 수입
Ventripoint Diagnostics Ltd.
$0.07
-4.2%
$0
종가: Aug 05, 16:00:00 GMT-4
$0.07
3.72%
$0
애프터마켓: Aug 05, 18:58:55 GMT-4
뒤로
Ventripoint Diagnostics Ltd. (VPTDF) 수입
Earnings FAQ
VPTDF의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Ventripoint Diagnostics Ltd. VPTDF의 지난 분기 매출 실적은 어땠나요?
Ventripoint Diagnostics Ltd.의 매출 추정치는 얼마인가요?
Ventripoint Diagnostics Ltd.의 수익 품질 점수는 얼마인가요?
Ventripoint Diagnostics Ltd.는 언제 수익을 보고하나요?
Ventripoint Diagnostics Ltd.의 예상 수익은 얼마인가요?
Ventripoint Diagnostics Ltd.은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.0785
시가
$0.078
일일 범위
$0.0741 - $0.0786
52주 범위
$0.0565 - $0.1367
거래량
40.0K
평균 거래량
110.6K
배당수익률
--
EPS(TTM)
-0.01
시가총액
$14.6M
VentriPoint Diagnostics Ltd.란 무엇인가요?
VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. The company is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. The company develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. The company provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. The company has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
